Literature DB >> 24340794

WHO Expert Committee on Biological Standardization.

.   

Abstract

This report presents the recommendations of a WHO expert committee commissioned to coordinate activities leading to the adoption of international recommendations for the production and control of vaccines and other biologicals and the establishment of international biological reference materials. The report starts with a discussion of general issues brought to the attention of the Committee and provides information on the status and development of reference materials for various antibodies, antigens, blood products and related substances, cytokines, growth factors, endocrinological substances and in vitro diagnostic devices. The second part of the report, of particular relevance to manufacturers and national regulatory authorities, contains revised WHO Recommendations for evaluation of animal cell cultures as substrates for the manufacture of biological medicinal products, for production and control of hepatitis B vaccines and for production and control of yellow fever vaccines. New WHO Guidelines on the independent lot release of vaccines are also included. Finally, there is an update to the procedure for the prequalification of vaccines. Also included are lists of Recommendations, Guidelines and other documents related to the manufacture and control of biological substances used in medicine, and of International Standards and Reference Reagents for biological substances.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24340794

Source DB:  PubMed          Journal:  World Health Organ Tech Rep Ser        ISSN: 0512-3054


  3 in total

1.  Clinical Experience of the Use of CT-P13, a Biosimilar to Infliximab in Patients with Inflammatory Bowel Disease: A Case Series.

Authors:  Yun-Seong Kang; Hyoung Ho Moon; Seung Eun Lee; Yun Jeong Lim; Hyoun Woo Kang
Journal:  Dig Dis Sci       Date:  2014-10-18       Impact factor: 3.199

2.  Xeno-free protocol for GMP-compliant manufacturing of human fetal pancreas-derived mesenchymal stem cells.

Authors:  Zahra Jabbarpour; Sajjad Aghayan; Babak Arjmand; Khadijeh Fallahzadeh; Sepideh Alavi-Moghadam; Bagher Larijani; Hamid Reza Aghayan
Journal:  Stem Cell Res Ther       Date:  2022-06-21       Impact factor: 8.079

3.  WHO working group meeting to amend WHO Recommendations to assure the quality, safety and efficacy of live attenuated yellow fever vaccines.

Authors:  Javier Martin; Alan David Thomas Barrett; Dianliang Lei; Philip Minor
Journal:  Vaccine       Date:  2022-05-09       Impact factor: 4.169

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.